PACE4-based molecular targeting of prostate cancer using an engineered ⁶⁴Cu-radiolabeled peptide inhibitor.
about
Novel Insights into Structure-Activity Relationships of N-Terminally Modified PACE4 Inhibitors.Multi-Leu PACE4 Inhibitor Retention within Cells Is PACE4 Dependent and a Prerequisite for Antiproliferative Activity.PACE4 inhibitors and their peptidomimetic analogs block prostate cancer tumor progression through quiescence induction, increased apoptosis and impaired neovascularisation.Proteomic Study to Survey the CIGB-552 Antitumor Effect
P2860
PACE4-based molecular targeting of prostate cancer using an engineered ⁶⁴Cu-radiolabeled peptide inhibitor.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
PACE4-based molecular targetin ...... adiolabeled peptide inhibitor.
@en
type
label
PACE4-based molecular targetin ...... adiolabeled peptide inhibitor.
@en
prefLabel
PACE4-based molecular targetin ...... adiolabeled peptide inhibitor.
@en
P2093
P2860
P1433
P1476
PACE4-based molecular targetin ...... adiolabeled peptide inhibitor.
@en
P2093
Brigitte Guérin
Christine Levesque
François D'Anjou
Frédéric Couture
Robert Day
Samia Ait-Mohand
Véronique Dumulon-Perreault
P2860
P304
P356
10.1016/J.NEO.2014.07.010
P577
2014-08-01T00:00:00Z